NCT01236820

Brief Summary

The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 5, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 9, 2010

Completed
Last Updated

November 9, 2010

Status Verified

November 1, 2010

First QC Date

November 5, 2010

Last Update Submit

November 8, 2010

Conditions

Keywords

L5LDLCardiovascular diseaseChronic kidney diseaseHemodialysis

Study Arms (3)

Normal

Healthy population

CKD Patients

Chronic Kidney Disease, in Stage III-V

HD patients

End-stage renal disease patients undergoing hemodialysis

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Residents in Taiwan, mostly in Taichung area

You may qualify if:

  • clinical diagnosis of CKD
  • clinical diagnosis of HD

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, Taiwan, 404, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood

MeSH Terms

Conditions

Cardiovascular DiseasesRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Chiz-Tzung Chang, Ph.D.

CONTACT

Chiu-Ching Huang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 5, 2010

First Posted

November 9, 2010

Study Start

September 1, 2010

Last Updated

November 9, 2010

Record last verified: 2010-11

Locations